ImmunoGen, Inc. (IMGN) is scheduled to report its results for the three months ended Sep 30, 2016 on Oct 28 before the opening bell.
- 24/7 Wall St.•12 days ago
October 14, 2016: Here are four stocks trading with relatively heavy volume among 57 equities making new 52-week lows in Friday’s session. On the NYSE, advancers led decliners by just better than an even ...
- Business Wire•12 days agoImmunoGen, Inc. Announces Conference Call to Discuss its Financial Results for Quarter Ended September 30
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m.
ImmunoGen, Inc. (IMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||1.00 x 300|
|Ask||2.70 x 500|
|Day's Range||2.17 - 2.27|
|52wk Range||2.17 - 14.22|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.33|
|Avg Vol (3m)||1,193,327|
|Dividend & Yield||N/A (N/A)|